183 related articles for article (PubMed ID: 30253878)
1. Although female patients with ankylosing spondylitis score worse on disease activity than male patients and improvement in disease activity is comparable, male patients show more radiographic progression during treatment with TNF-α inhibitors.
van der Slik B; Spoorenberg A; Wink F; Bos R; Bootsma H; Maas F; Arends S
Semin Arthritis Rheum; 2019 Apr; 48(5):828-833. PubMed ID: 30253878
[TBL] [Abstract][Full Text] [Related]
2. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
3. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
[TBL] [Abstract][Full Text] [Related]
4. Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.
Maas F; Spoorenberg A; Brouwer E; Bos R; Efde M; Chaudhry RN; Veeger NJ; van Ooijen PM; Wolf R; Bootsma H; van der Veer E; Arends S
PLoS One; 2015; 10(4):e0122693. PubMed ID: 25879956
[TBL] [Abstract][Full Text] [Related]
5. Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.
Webers C; Essers I; Ramiro S; Stolwijk C; Landewé R; van der Heijde D; van den Bosch F; Dougados M; van Tubergen A
Rheumatology (Oxford); 2016 Mar; 55(3):419-28. PubMed ID: 26385369
[TBL] [Abstract][Full Text] [Related]
6. Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies.
Maas F; Spoorenberg A; Brouwer E; van der Veer E; Bootsma H; Bos R; Wink FR; Arends S
Semin Arthritis Rheum; 2017 Apr; 46(5):562-568. PubMed ID: 28040243
[TBL] [Abstract][Full Text] [Related]
7. Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors.
Maas F; Arends S; Wink FR; Bos R; Bootsma H; Brouwer E; Spoorenberg A
PLoS One; 2017; 12(6):e0177231. PubMed ID: 28640818
[TBL] [Abstract][Full Text] [Related]
8. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
[TBL] [Abstract][Full Text] [Related]
9. Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice.
Arends S; Brouwer E; Efde M; van der Veer E; Bootsma H; Wink F; Spoorenberg A
Clin Exp Rheumatol; 2017; 35(1):61-68. PubMed ID: 27749222
[TBL] [Abstract][Full Text] [Related]
10. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
11. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Molnar C; Scherer A; Baraliakos X; de Hooge M; Micheroli R; Exer P; Kissling RO; Tamborrini G; Wildi LM; Nissen MJ; Zufferey P; Bernhard J; Weber U; Landewé RBM; van der Heijde D; Ciurea A;
Ann Rheum Dis; 2018 Jan; 77(1):63-69. PubMed ID: 28939631
[TBL] [Abstract][Full Text] [Related]
12. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
Barkham N; Kong KO; Tennant A; Fraser A; Hensor E; Keenan AM; Emery P
Rheumatology (Oxford); 2005 Oct; 44(10):1277-81. PubMed ID: 16105913
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-tumor necrosis factor α treatment on radiographic progression in patient with ankylosing spondylitis: A systematic review and meta-analysis.
Zong HX; Xu SQ; Tong H; Wang XR; Pan MJ; Teng YZ
Mod Rheumatol; 2019 May; 29(3):503-509. PubMed ID: 30220240
[TBL] [Abstract][Full Text] [Related]
14. Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study.
Nam B; Koo BS; Lee TH; Shin JH; Kim JJ; Lee S; Joo KB; Kim TH
BMC Musculoskelet Disord; 2021 Feb; 22(1):140. PubMed ID: 33541326
[TBL] [Abstract][Full Text] [Related]
15. An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
Pham T; Landewé R; van der Linden S; Dougados M; Sieper J; Braun J; Davis J; Rudwaleit M; Collantes E; Burgos-Vargas R; Edmonds J; Olivieri I; van der Horst-Bruinsma I; Mielants H; Stone M; Emery P; van der Heijde D
Ann Rheum Dis; 2006 Dec; 65(12):1620-5. PubMed ID: 16464984
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
17. Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis.
Maas F; Arends S; Brouwer E; Bootsma H; Bos R; Wink FR; Spoorenberg A
Arthritis Res Ther; 2017 Apr; 19(1):77. PubMed ID: 28441960
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
19. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.
Haroon N; Inman RD; Learch TJ; Weisman MH; Lee M; Rahbar MH; Ward MM; Reveille JD; Gensler LS
Arthritis Rheum; 2013 Oct; 65(10):2645-54. PubMed ID: 23818109
[TBL] [Abstract][Full Text] [Related]
20. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
Vastesaeger N; Cruyssen BV; Mulero J; Gratacós Masmitjá J; Zarco P; Almodovar R; Font P; Juanola X; Collantes-Estevez E;
Reumatol Clin; 2014; 10(4):204-9. PubMed ID: 24598027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
